Addus HomeCare Corporation (ADUS) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2025)
ADUS's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
ADUS Revenue Analysis (2014–2025)
As of March 1, 2026, Addus HomeCare Corporation (ADUS) generated trailing twelve-month (TTM) revenue of $1.42 billion, reflecting exceptional growth of +25.6% year-over-year. The most recent quarter (Q4 2025) recorded $373.1 million in revenue, up 3.0% sequentially.
Looking at the longer-term picture, ADUS's 5-year compound annual growth rate (CAGR) stands at +13.2%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $1.42 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows ADUS's business is primarily driven by Personal Care (77%), Hospice (18%), and Home Health (5%). With over half of revenue concentrated in Personal Care, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including CHE (+4.1% YoY), OPCH (+13.0% YoY), and AVAH (+11.5% YoY), ADUS has outperformed the peer group in terms of revenue growth. Compare ADUS vs CHE →
Peer Comparison
Compare ADUS's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ADUSCurrent | $1.4B | +25.6% | +13.2% | 9.7% | |
| CHE | $2.5B | +4.1% | +4.0% | 13.4% | |
| OPCH | $5.6B | +13.0% | +13.3% | 6.0% | |
| AVAH | $2.0B | +11.5% | +7.9% | 6.9% | |
| EHAB | $1.0B | +1.0% | - | -11.1% | |
| DCGO | $617M | -47.0% | +66.4% | 4.7% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.42B | +23.2% | $461.9M | 32.5% | $138.6M | 9.7% |
| 2024 | $1.15B | +9.1% | $375.0M | 32.5% | $102.7M | 8.9% |
| 2023 | $1.06B | +11.3% | $339.9M | 32.1% | $91.0M | 8.6% |
| 2022 | $951.1M | +10.0% | $299.7M | 31.5% | $68.7M | 7.2% |
| 2021 | $864.5M | +13.0% | $269.8M | 31.2% | $65.9M | 7.6% |
| 2020 | $764.8M | +17.9% | $226.2M | 29.6% | $44.5M | 5.8% |
| 2019 | $648.8M | +25.2% | $179.2M | 27.6% | $34.8M | 5.4% |
| 2018 | $518.1M | +21.7% | $138.3M | 26.7% | $22.8M | 4.4% |
| 2017 | $425.7M | +6.2% | $115.6M | 27.2% | $25.3M | 5.9% |
| 2016 | $400.7M | +19.0% | $106.1M | 26.5% | $15.5M | 3.9% |
See ADUS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ADUS Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ADUS vs AGIO
See how ADUS stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is ADUS's revenue growth accelerating or slowing?
ADUS revenue is accelerating at +25.6% year-over-year, exceeding the 5-year CAGR of +13.2%. TTM revenue reached $1.4B. Growth momentum has increased versus prior periods.
What is ADUS's long-term revenue growth rate?
Addus HomeCare Corporation's 5-year revenue CAGR of +13.2% reflects the sustained expansion pattern. Current YoY growth of +25.6% is above this long-term average.
How is ADUS's revenue distributed by segment?
ADUS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.